FDA ends investigation of embryo broker

This version of Fda Ends Investigation Embryo Broker Flna1C9471346 - Health and Medicine | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

The Food and Drug Administration has ended an investigation into a broker offering ready-made embryos to prospective parents, concluding the agency had no jurisdiction.

The FDA has not disclosed what laws or regulations were the focus of the investigation into Jennalee Ryan’s Abraham Center of Life. The agency’s statement Wednesday said “the investigation determined the facility was not currently engaged in practices that fall under FDA jurisdiction.”

Ryan’s service involves a physician who uses donated eggs and sperm to create embryos that cost $5,000 a pair. Clients can review the donors’ characteristics, including their ethnic and educational background and, in some cases, their photos.

Some critics have said Ryan’s business may be crossing ethical lines by marketing a better baby.

But Ryan said she’s just trying to help couples or single women, for example, who may not be able to have a biological baby.

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone